Advertisements



Boston Scientific"s 25 mm Lotus Valve Wins CE Mark - Analyst Blog

Management at Boston Scientific (BSX) is enthusiastic about the commercial launch of the Lotus Valve system only seven months after its initial launch revealing their commitment to improving therapy modes and patient outcomes. Massachusetts-b.....»»

Category: topSource: zacksJul 16th, 2014

Medtronic begins initial European launch of MiniMed Duo

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fly's real-time, streaming news feed keeps individual investors, professional money managers, active trader.....»»

Category: blogSource: theflyonthewallJun 3rd, 2014

Horizon Pharma"s (HZNP) CEO Tim Walbert on Q1 2014 Results - Earnings Call Transcript

Horizon Pharma, Inc. (HZNP) Q1 2014 Results Earnings Conference Call May 09, 2014 08:00 AM ET Executives Bob De Vaere - EVP and Chief Financial Officer Tim Walbert - Chairman, President and CEO Tod Smith - EVP and Chief Commercial Officer Analysts.....»»

Category: topSource: seekingalphaMay 9th, 2014

Horizon Pharma Has Significant Growth Potential

By ONeil Trader:Horizon Pharma (HZNP) had a truly transformational year in 2013, and is set to deliver strong revenue growth and achieve non-GAAP profitability in 2014. The company successfully marketed Duexis and Rayos, acquired the rights for Vimovo fro.....»»

Category: topSource: seekingalphaMar 20th, 2014

Buy Horizon Pharma On Upcoming Revenue Growth

By Equity Flux: Introduction Horizon Pharma develops and commercializes products that target arthritis, pain and inflammatory diseases. The company is currently marketing Duexis, Rayos/Lodotra and the newly acquired Vimovo to orthopedic surgeons and rhe.....»»

Category: topSource: seekingalphaMar 5th, 2014

Horizon Pharma Issues Update on Feb. 10-11th FDA Joint Panel Meeting on CV Risk of NSAIDs

Horizon Pharma, Inc., (NASDAQ: HZNP), a commercial stage, specialty pharmaceutical company that markets two gastroprotective nonsteroidal anti-inflammatory drugs (NSAIDs), VIMOVO(R) (naproxen/esomeprazole magnesium) and DUEXIS(R) (ibuprofen and famotidine.....»»

Category: blogSource: benzingaFeb 11th, 2014

Horizon Pharma says Par to withdraw ANDA for generic Rayos

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fly's real-time, streaming news feed keeps individual investors, professional money managers, active trader.....»»

Category: blogSource: theflyonthewallNov 22nd, 2013

Volcano Launches Crux Vena Cava Filter - Analyst Blog

Volcano expands Product portfolio with the commercial launch of Crux Vena Cava Filter Volcano Corporation (VOLC) announced the commercial release as well as the initial implantations of the novel device – Crux Vena Cava Filter (VCF). Th.....»»

Category: topSource: zacksNov 14th, 2013

Horizon Pharma Continues Cash Burn And Dilution

By Chimera Research Group: By Patrick Crutcher We last wrote on Horizon Pharma (HZNP) following their FDA approval of RAYOS, but seems not much has changed. However, the stock has risen roughly 60% year to date with no apparent change in fundamentals. W.....»»

Category: topSource: seekingalphaNov 8th, 2013

Horizon Pharma presents newe clinical data on Rayos DR tablets

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fly's real-time, streaming news feed keeps individual investors, professional money managers, active trader.....»»

Category: blogSource: theflyonthewallOct 29th, 2013

Horizon Pharma Reports Clinical Data on RAYOS Tablets Which Will Be Presented at American College of Rheumatology Annual Meeting

Horizon Pharma, Inc (NASDAQ: HZNP) today announced that two published abstracts of its approved treatment RAYOS(R) (prednisone) delayed-release tablets will be presented during the American College of Rheumatology (ACR)/Association of Rheumatology Health .....»»

Category: blogSource: benzingaOct 21st, 2013

Source ETFs Unveils Euro Stoxx 50 Fund as Initial U.S. Offering

Source is a major ETF provider in Europe and now the asset manager has its sights set on America with its first product launch......»»

Category: personalSource: thestreetSep 16th, 2014

Update: Marathon Patent Announces Launch Of Opus Analytics And Names CMO

By Mobile Guru:On September 15th, Marathon Patent Group (NASDAQ:MARA) announced the commercial launch of the Opus™ Patent Analysis Platform. Opus includes a set of proprietary analytical tools that offer an unparalleled ability to both quickly evaluate .....»»

Category: topSource: seekingalphaSep 16th, 2014

Horizon Pharma to host special shareholder meeting

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fly's real-time, streaming news feed keeps individual investors, professional money managers, active trader.....»»

Category: blogSource: theflyonthewallSep 16th, 2014

Markets Mixed on Tech Sell-Off and Interest Rate Concerns

The U.S. markets were a mixed bag Monday. The blue chips posted gains, while tech stocks were particularly hard hit ahead of Alibaba’s IPO, which is slated to launch later this week and could be the largest initial offering in history......»»

Category: marketSource: foxnewsSep 15th, 2014

As Obamacare"s Second Rollout Begins, Avoid These Plans and Scams

NEW YORK (MainStreet) -- The secondaAffordable Care Act (ACA) open enrollment period is just weeks away but some Americans are still reeling from scams spawned by the initial Obamacare rollout. The Federal Trade Commission is mopping up the mess from las.....»»

Category: topSource: thestreetSep 15th, 2014

Horizon Pharma valuation at attractive entry point, says Cowen

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fly's real-time, streaming news feed keeps individual investors, professional money managers, active trader.....»»

Category: blogSource: theflyonthewallSep 15th, 2014

Citizens Bank launches national technology banking group

RBS Citizens, the commercial banking division of Citizens Financial Group, Thursday announced the national launch of its technology and services banking group, which started in Boston seven years ago. The national rollout of the technology and services g.....»»

Category: topSource: bizjournalsSep 11th, 2014

Alibaba IPO covered after first few roadshow meetings: Sources - Times of India

Times of IndiaAlibaba IPO covered after first few roadshow meetings: SourcesTimes of IndiaAlibaba Group Holding has received enough orders for its record-breaking initial public offering to cover the entire deal within just two days of its launch, people .....»»

Category: topSource: googlenewsSep 11th, 2014

Alibaba"s record IPO covered after first few roadshow meetings: sources

(Reuters) - Alibaba Group Holding Ltd has received enough orders for its record-breaking initial public offering to cover the entire deal within just two days of its launch, people familiar with the IPO process said on Wednesday......»»

Category: topSource: reutersSep 10th, 2014